Crystal-induced arthritis in prosthetic joints: a systematic review of clinical features, diagnosis, management, and outcomes

Table 3 Treatment and outcomes of patients with gout or calcium pyrophosphate deposition disease in prosthetic joints

	N (%) or Median (IQR)
Treatment
Surgery	13/44 (29.5)
Systemic glucocorticoid	11/44 (25.0)
Intraarticular glucocorticoid	2/44 (4.5)
Colchicine	18/44 (40.9)
Antibiotics	15/43 (34.9)
NSAIDs	21/44 (47.7)
Allopurinol	8/44 (18.2)
Time from Therapeutic Initiation to Symptomatic Resolution (days)	4.0 (2.3–7.0)
Death	0/44 (0)

Abbreviations NSAID; nonsteroidal anti-inflammatory drug
* Prevalence here is defined as the number of cases that reported the variable divided by the number of the total cases

ISSN: 2520-1026